Expression Analysis, a regulatory compliant genomic services laboratory, combines whole-genome microarray and sequencing capabilities with single-gene analysis to speed pharmaceutical development and clinical diagnostics applications. Its emphasis on genetic variation in diseases allows its clients to make products that will eventually play a role in delivery of personalized medicine. The company has developed a number of analytic tools to assist its clients in getting more and better information from the data generated in its laboratory. Steve McPhail, Expression Analysis President & Chief Executive Officer, along with other individuals in the organization, has worked with the FDA to set the industry standards for submission of genomic datasets. As a result, data generated by Expression Analysis meets or exceeds those standards, making regulatory submissions for its clients much easier.
展开▼
